Julie Manon

Dr. Julie Manon

Université catholique de Louvain, Brussels, Brussels-Capital Region, Belgium
orcid
PT, MD, PhD Student

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
OCOlivier Cornu
Olivier Cornu
JMJulie Manon
Julie Manon
KTKarim Tribak
Karim Tribak
DPDan Putineanu
Dan Putineanu

1 May 2019 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
JMJulie Manon
Julie Manon
DCDetrembleur Christine
Detrembleur Christine
SVSimon Van de Veyver
Simon Van de Veyver
KTKarim Tribak
Karim Tribak
OCOlivier Cornu
Olivier Cornu
DPDan Putineanu
Dan Putineanu

1 April 2020 in Hand Surgery and Rehabilitation
Verified
Journal Article
Closed access
BDB. Decot
B. Decot
JMJulie Manon
Julie Manon
GLG. Lambeaux
G. Lambeaux
DMD. Mathieu
D. Mathieu
OBO. Barbier
O. Barbier
XLX. Libouton
X. Libouton

19 October 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
JMJulie Manon
Julie Manon
RERobin Evrard
Robin Evrard
LMLouis Maistriaux
Louis Maistriaux
LFLies Fievé
Lies Fievé
UHUgo Heller
Ugo Heller
OCOlivier Cornu
Olivier Cornu
Introduction: The human fascia lata (HFL) is used widely in reconstructive surgery in indications other than fracture repair. The goal of this study was to compare microscopic, molecular, and mechanical properties of HFL and periosteum (HP) from a bone tissue engineering perspective.Material and Methods: Cadaveric HP and HFL (N = 4 each) microscopic morphology was characterized using histology and immunohistochemistry (IHC), and the extracellular matrix (ECM) ultrastructure assessed by means of scanning electron microscopy (SEM). DNA, collagen, elastin, glycosaminoglycans, major histocompatibility complex Type 1, and bone morphogenetic protein (BMP) contents were quantified. HP (N = 6) and HFL (N = 11) were submitted to stretch tests.Results: Histology and IHC highlighted similarities (Type I collagen fibers and two-layer organization) but also differences (fiber thickness and compaction and cell type) between both tissues, as confirmed using SEM. The collagen content was statistically higher in HFL than HP (735 vs. 160.2 μg/mg dry weight, respectively, p < 0.0001). On the contrary, DNA content was lower in HFL than HP (404.75 vs. 1,102.2 μg/mg dry weight, respectively, p = 0.0032), as was the immunogenic potential (p = 0.0033). BMP-2 and BMP-7 contents did not differ between both tissues (p = 0.132 and p = 0.699, respectively). HFL supported a significantly higher tension stress than HP.Conclusion: HP and HFL display morphological differences, despite their similar molecular ECM components. The stronger stretching resistance of HFL can specifically be explained by its higher collagen content. However, HFL contains many fewer cells and is less immunogenic than HP, as latter is rich in periosteal stem cells. In conclusion, HFL is likely suitable to replace HP architecture to confer a guide for bone consolidation, with an absence of osteogenicity. This study could pave the way to a bio-engineered periosteum built from HFL.

2 August 2024 in Biomaterials
Verified
Journal Article
Closed access
JMJulie Manon
Julie Manon
RERobin Evrard
Robin Evrard
LMLouis Maistriaux
Louis Maistriaux
LFLies Fieve
Lies Fieve
DXDaela Xhema
Daela Xhema
OCOlivier Cornu
Olivier Cornu

21 January 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
JMJulie Manon
Julie Manon
RERobin Evrard
Robin Evrard
LFLies Fievé
Lies Fievé
Caroline BouzinCaroline Bouzin
Caroline Bouzin
DMDelphine Magnin
Delphine Magnin
OCOlivier Cornu
Olivier Cornu
The lack of viability of massive bone allografts for critical-size bone defect treatment remains a challenge in orthopedic surgery. The literature has reviewed the advantages of a multi-combined treatment with the synergy of an osteoconductive extracellular matrix (ECM), osteogenic stem cells, and growth factors (GFs). Questions are still open about the need for ECM components, the influence of the decellularization process on the latter, the related potential loss of function, and the necessity of using pre-differentiated cells. In order to fill in this gap, a bone allograft surrounded by an osteogenic membrane made of a decellularized collagen matrix from human fascia lata and seeded with periosteal mesenchymal stem cells (PMSCs) was analyzed in terms of de-/recellularization, osteogenic properties, PMSC self-differentiation, and angiogenic potential. While the decellularization processes altered the ECM content differently, the main GF content was decreased in soft tissues but relatively increased in hard bone tissues. The spontaneous osteogenic differentiation was necessarily obtained through contact with a mineralized bone matrix. Trying to deepen the knowledge on the complex matrix–cell interplay could further propel these tissue engineering concepts and lead us to provide the biological elements that allow bone integration in vivo.